MDE Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$495K Sell
6,813
-205
-3% -$14.6K 0.13% 27
2014
Q4
$484K Sell
7,018
-170
-2% -$11.5K 0.12% 27
2014
Q3
$466K Sell
7,188
-910
-11% -$57.6K 0.12% 24
2014
Q2
$503K Sell
8,098
-15
-0.2% -$895 0.12% 27
2014
Q1
$478K Buy
8,113
+280
+4% +$15.6K 0.1% 30
2013
Q4
$399K Sell
7,833
-120
-2% -$6.01K 0.07% 39
2013
Q3
$400K Sell
7,953
-520
-6% -$27.2K 0.06% 34
2013
Q2
$416K Buy
+8,473
New +$461K 0.07% 33

Other funds holding LLY

MDE Group's LLY Position: Q1 2015 in Review

MDE Group reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2015, selling an estimated $14.6K and leaving 6,813 shares worth $495K. The position accounts for 0.13% of the portfolio, ranked #27.

MDE Group first reported a position in LLY in Q2 2013 and has held it in 8 quarters since. The position peaked at $503K in Q2 2014. 1,118 funds tracked by Wall St. Rank hold LLY as of Q1 2015.

  • MDE Group held 6,813 shares of Eli Lilly worth $495K as of Q1 2015.
  • MDE Group sold 205 Eli Lilly shares in Q1 2015, an estimated $14.6K.
  • Eli Lilly made up 0.13% of MDE Group's portfolio in Q1 2015, its #27 holding.
  • MDE Group first reported a position in Eli Lilly in Q2 2013 and has held it in 8 quarters since.
  • MDE Group's Eli Lilly position peaked at $503K in Q2 2014.
  • 1,118 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2015.

Based on MDE Group's 13F filing for Q1 2015, filed 22 Apr 2015.